Rainer Kotz

Learn More
Autoantibodies to the heat shock protein 90 (Hsp 90) have been reported as prognostic marker in breast cancer patients. Sera from 20 high-grade osteosarcoma patients were tested at the time of diagnosis by enzyme-linked immunosorbent assay. Presence of anti-Hsp90 antibodies correlated with a better response to neoadjuvant chemotherapy (P < 0.01), whereas(More)
I wi Brou t t Bowrr. Corporare Rescwc-li CRB. CH-.The performance of highly doped SnO, anodes for the oxidative treatment of biologically refractory ~ a s t e water was compared with PbO, and Pt. The oxidation of a wide range of organic compounds proceeds with a n efficiency which is about 5 times higher than with platinum anodes. The oxidation efficiency(More)
Purpose. The present prospective randomized adjuvant trial was carried out to compare the toxicity, feasibility and efficacy of augmented chemotherapy added to hyperfractionated accelerated radiotherapy after wide or marginal resection of grade 2 and grade 3 soft tissue sarcoma (STS).Patients and methods. Fifty-nine patients underwent primary surgery by(More)
Introduction: An analysis was performed in order to determine which of the prospectively collected variables included in the COSS-database might correlate with survival in osteosarcoma. Patients and methods: All 1702 patients with previously untreated (except primary surgery) high-grade osteosarcoma of the extremity or trunk registered into a neoadjuvant(More)
  • 1